Sanofi India gained 1.54% to Rs 4,388 at 14:50 IST on BSE after net profit rose 24.96% to Rs 80.60 crore on 12.13% rise in total income to Rs 570 crore in Q1 March 2016 over Q1 March 2015.
The result was announced during market hours today, 29 april 2016.Meanwhile, the BSE Sensex was down 126.08 points, or 0.49%, to 25,477.02.
On BSE, so far 4,194 shares were traded in the counter, compared with an average volume of 2,138 shares in the past one quarter. The stock hit a high of Rs 4,502.75 and a low of Rs 4,280 so far during the day. The stock had hit a record high of Rs 4,651.10 on 13 November 2015. The stock had hit a 52-week low of Rs 3,091 on 12 May 2015. The stock had outperformed the market over the past one month till 28 April 2016, gaining 5.38% compared with Sensex's 2.55% rise. The scrip had, however, underperformed the market in past one quarter, advancing 3.3% as against Sensex's 4.63% rise.
The large-cap pharma company has equity capital of Rs 23.03 crore. Face value per share is Rs 10.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. In India, Sanofi operates through four entities - Sanofi India, Sanofi-Synthelabo (India), Sanofi Pasteur India, and Shantha Biotechnics.
Powered by Capital Market - Live News
